Bone Graft News and Research

RSS

New technique allows researchers to create large scale, personalized bone grafts

Scientists from the New York Stem Cell Foundation Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering.

18 Jul 2018

Novel bioengineering technique could help repair bone defects

Researchers have developed a bone engineering technique that uses stem cells to improve bone grafts for the treatment of bone injury or disease.

18 Jul 2018

Biotechnology startup receives FDA clearance for synthetic bone graft substitute

A biotechnology startup enabled by UC Davis, Molecular Matrix Inc., has received Food and Drug Administration clearance for a carbohydrate-based polymer that can help injured bones heal and regrow.

27 Jan 2018

Treating cartilage grafts with bone marrow concentrate before joint replacement speeds recovery

Biologic joint restoration using donor tissue instead of traditional metal and plastic may be an option for active patients with joint defects. Although recovery from a biologic joint repair is typically longer than traditional replacement, successful biologic restoration allows patients to return to full activity. However, in some cases, the transplanted bone does not heal correctly.

25 Sep 2017

Study examines novel surgical procedure to combat peri-implantitis

Peri-implantitis is an irreversible inflammatory disease that is commonly caused by plaque and biofilm that accumulates on the exterior of a dental implant. It effects both the soft and hard tissues surrounding the implant, and without treatment, may result in excessive bone loss proximal to the implant and its eventual failure.

5 Jul 2017

Scientists design bioactive nanomaterial that excels at stimulating bone regeneration

There hasn't been a gold standard for how orthopaedic spine surgeons promote new bone growth in patients, but now Northwestern University scientists have designed a bioactive nanomaterial that is so good at stimulating bone regeneration it could become the method surgeons prefer.

19 Jun 2017

Product to assist bone formation in spinal fusion surgery released by DePuy Synthes

DePuy Synthes*, in collaboration with LifeNet Health®, launches ViviGen Formable™ Cellular Bone Matrix**, a second generation cellular allograft used to assist in the formation of bone during spinal fusion surgery. ViviGen Formable augments the DePuy Synthes biomaterials portfolio and joins the first generation, ViviGen® Cellular Bone Matrix, which launched in late 2014. With both ViviGen and ViviGen Formable, surgeons may now choose a preferred handling option based on the needs of each surgical case.

16 Feb 2017

K2M announces U.S. launch of innovative 3D-printed CASCADIA product portfolio at 2016 NASS meeting

K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced the U.S. launch of its award-winning CASCADIA Interbody Systems, featuring Lamellar 3D Titanium Technology, during the 31st North American Spine Society (NASS) Annual Meeting, Oct. 26-29, 2016, in Boston at Booth #1615.

27 Oct 2016

New scaffold could improve outcome of periodontal regenerative surgery

A new regenerative scaffold made of biosafe collagen hydrogel and collagensponge could possess the ability of retaining fibroblastic growth factor-2 (FGF2) and stimulate the periodontal tissue regeneration, according to new research published in The Open Dentistry Journal.

24 Oct 2016

New reconstruction technique restores bone loss in the jaw of pigs

Researchers have engineered living bone tissue to repair bone loss in the jaw, a structure that is typically difficult to restore.

5 Aug 2016

Pivotal IDE clinical trial results for Cerapedics' i-FACTOR bone graft in ACDF procedures published in journal Spine

Cerapedics, a privately-held orthobiologics company, announced today results from a pivotal FDA Investigational Device Exemption (IDE) clinical trial for i-FACTOR Peptide Enhanced Bone Graft in anterior cervical discectomy and fusion (ACDF) procedures have been electronically published in the peer-reviewed journal Spine.

8 Feb 2016

MiMedx Group agrees to buy Stability Biologics

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, announced today that it has signed a definitive agreement to acquire Stability Inc., d/b/a Stability Biologics, a provider of human tissue products to surgeons, facilities and distributors serving the surgical, spine and orthopedics sectors of the healthcare industry.

11 Jan 2016

QMUL-led scientists develop new type of synthetic bone graft

Scientists led by Queen Mary University of London (QMUL) have developed a new type of synthetic bone graft that boosts the body's own ability to regenerate bone tissue and could produce better outcomes for patients.

18 Dec 2015

New study refutes increased cancer risk for patients undergoing spinal fusion surgery with rhBMP

A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP). The study appears in November 15 issue of Spine, published by Wolters Kluwer.

13 Nov 2015

Cerapedics' i-FACTOR Peptide Enhanced Bone Graft gets FDA approval for use in cervical spine surgery

Cerapedics, a privately-held orthobiologics company, announced today the U.S. Food and Drug Administration (FDA) has approved the company’s Premarket Approval (PMA) application for i-FACTOR™ Peptide Enhanced Bone Graft for use in anterior cervical discectomy and fusion (ACDF) procedures in patients with degenerative cervical disc disease. i-FACTOR bone graft is the first bone graft to be approved for use in the cervical spine and only the second PMA-approved bone graft in the spine.

4 Nov 2015

Biodegradable polymer could help heal the bones of patients with orthopedic injuries

A plastic derived from cornstarch combined with a volcanic ash compound, Montmorillonite clay, could help heal the bones of hundreds of thousands of patients with orthopedic injuries who need bone replacement after tumor removal, spinal fusion surgery or fracture repair.

28 Oct 2015

DTR Medical to showcase new Bone Trephine product for paediatric cleft surgery at MEDICA 2015

Award-winning UK manufacturer of innovative and high quality single-use surgical instruments DTR Medical, will showcase its new Bone Trephine product at MEDICA - the world’s largest medical trade fair.

23 Oct 2015

New orthobiologics products can benefit both patients and surgeons

Autografts, the gold standard of bone grafts, have several limitations. As a result, new orthobiologics products are being developed for the benefit of patients as well as surgeons.

22 Jul 2015

Bone-tendon-bone grafts and hamstring autografts equally viable options for healing injured ACL

Surgeons making reconstruction choices for an injured ACL can consider both bone-tendon-bone grafts and hamstring autografts as equally viable options in regards to healing, as reported in research today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in Orlando, FL.

9 Jul 2015

FDA grants first cervical multilevel indication to Centinel Spine’s STALIF C integrated interbody device

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile, Integrated Interbody fusion devices was granted the first cervical multilevel indication for a Stand-Alone interbody device by the U.S. Food and Drug Administration (FDA).

30 Jun 2015